Can undiagnosed Lyme disease cause neurologic disorders such as ataxia and mimic Parkinson disease or multiple sclerosis?

Undiagnosed Lyme Disease Does NOT Typically Cause Parkinson's or MS-Like Syndromes

Do not routinely test for Lyme disease in patients presenting with typical Parkinson's disease, relapsing-remitting multiple sclerosis, or ataxia unless there is specific clinical or epidemiologic support for Lyme disease. The 2020 IDSA/AAN/ACR guidelines provide a strong recommendation against routine testing for Lyme disease in these presentations 1.

Key Clinical Distinctions

While Lyme neuroborreliosis can affect the nervous system, it presents with a distinct pattern that differs fundamentally from Parkinson's disease or MS:

What Lyme Neuroborreliosis Actually Causes:

• Acute presentations: meningitis, painful radiculoneuritis, cranial neuropathies (especially facial nerve palsy), mononeuropathy multiplex, or spinal cord inflammation with associated radiculitis 1
• These are acute or subacute processes, not the chronic progressive course typical of Parkinson's or relapsing-remitting pattern of MS
• Nearly always accompanied by other clinical clues: prior erythema migrans rash, tick exposure in endemic areas, or systemic symptoms 2

What Lyme Does NOT Typically Cause:

• Typical Parkinson's disease with classic bradykinesia, rigidity, and resting tremor
• Relapsing-remitting MS with its characteristic temporal and spatial dissemination
• Isolated ataxia without other acute neurologic findings

The Evidence Against Routine Testing

The guidelines explicitly state to recommend against routine Lyme testing in patients with typical presentations of these neurodegenerative diseases (strong recommendation, low-quality evidence) 1. This recommendation prioritizes avoiding:

• False positive serologies leading to unnecessary antibiotic treatment
• Delayed diagnosis of the actual underlying condition
• Misattribution of symptoms to "chronic Lyme disease"

When to Actually Consider Lyme Testing

Only test when ALL of the following are present:

1. Epidemiologic plausibility: tick exposure in Lyme-endemic areas (Northeast, upper Midwest, Northern California)
2. Acute or subacute onset (not chronic progressive over years)
3. Specific neurologic patterns: meningitis, cranial neuropathies, painful radiculoneuritis, or mononeuropathy multiplex 1
4. Supporting clinical features: history of erythema migrans, constitutional symptoms, or other organ involvement

Critical Pitfalls to Avoid

The "Great Imitator" myth: While older literature 3, 4 referred to Lyme as the "new great imitator," this has led to significant overdiagnosis. The reality is that Lyme neuroborreliosis has a recognizable clinical pattern when properly evaluated 2.

Positive serology does not equal causation: Case reports exist of patients with both positive Lyme serology and MS-like disease 5, but this likely represents coincidental exposure to Borrelia burgdorferi in endemic areas, not causation. The consensus is clear that there is no etiologic association between Lyme disease and MS 6.

Rare exceptions exist but are pathologically distinct: One case report 7 described striatonigral degeneration (a form of multiple system atrophy) in a patient with documented Lyme infection, but this showed no classic neuroborreliosis findings at autopsy and represents an extraordinarily rare occurrence that should not drive clinical decision-making.

Diagnostic Approach for Atypical Cases

If you encounter atypical presentations with some features suggestive of both neurodegenerative disease AND possible Lyme exposure:

1. Perform standard two-tier serologic testing (ELISA followed by Western blot if positive) 1, 2
2. If serology is positive AND clinical suspicion remains high: obtain CSF for pleocytosis, elevated protein, and intrathecal antibody production 1, 2
3. Remember: CSF pleocytosis or pathogen-specific intrathecal antibody production is required to diagnose CNS Lyme infection 2
4. If testing is negative: pursue the appropriate workup for Parkinson's disease, MS, or other neurodegenerative conditions

The bottom line: In patients with typical presentations of Parkinson's disease, MS, or isolated ataxia without acute inflammatory features or epidemiologic risk factors, Lyme disease is not the diagnosis, and testing will cause more harm than good through false positives and diagnostic confusion.